δ-Thalassemia caused by disruption of the site for an erythroid-specific transcription factor, GATA-1, in the δ-globin gene promoter

Miho Matsuda, N. Sakamoto, Y. Fukumaki

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Delta-thalassemia is a complex group of inherited disorders of globin genes characterized by impaired synthesis of the δ-globin chain. The T-C substitution was detected at position -77 of the δ-globin gene isolated from three independent Japanese individuals who were homozygotes for δ- thalassemia. To elucidate the significance of the mutation in δ-globin gene expression, we investigated the genotype of three δ-thalassemia homozygotes and 58 normal individuals using dot blot hybridization of the polymerase chain reaction (PCR)-amplified DNA. The mutation was observed in six alleles of three homozygotes, while no mutation was detected in 116 alleles of normal individuals, thereby indicating the close association of this mutation with the thalassemia phenotype. Since the mutation (TTATCT-TCATCT) is located within the inverted binding motif of GATA-1 (T or A-G-A-T-A-G or A), an erythroid cell-specific transcription factor, we did gel retardation assays using nuclear extracts from the erythroid cells. We found that GATA-1 binds the oligonucleotide spanning positions -61 to -90, but does not bind to the oligonucleotide with the mutation at position -77. Competition gel retardation assays showed that GATA-1 binding can be competed out by the fragment with the GATA-1 motif, but not with the mutant oligonucleotide. Analysis of the transient expression of the CAT gene linked to the δ-globin gene promoter region demonstrated that the construct with the mutant promoter region was expressed about 20-fold less compared with the normal one. Thus, the mutation at position -77 impairs δ-globin gene expression by abolishing GATA-1 binding to the AGATAA sequence of the promoter region of the δ-globin gene. This provides a good example of involvement of tissue-specific transacting factors in the molecular pathogenesis of hereditary diseases.

Original languageEnglish
Pages (from-to)1347-1351
Number of pages5
JournalBlood
Volume80
Issue number5
Publication statusPublished - Jan 1 1992

Fingerprint

GATA Transcription Factors
Thalassemia
Globins
Genes
Mutation
Homozygote
Genetic Promoter Regions
Oligonucleotides
Erythroid Cells
Electrophoretic Mobility Shift Assay
Gene Expression
Gene expression
delta-Thalassemia
Assays
Gels
Alleles
Inborn Genetic Diseases
Polymerase chain reaction
Substitution reactions
Transcription Factors

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

δ-Thalassemia caused by disruption of the site for an erythroid-specific transcription factor, GATA-1, in the δ-globin gene promoter. / Matsuda, Miho; Sakamoto, N.; Fukumaki, Y.

In: Blood, Vol. 80, No. 5, 01.01.1992, p. 1347-1351.

Research output: Contribution to journalArticle

@article{2582788d66fd491bbc0c09dc4b8ddb41,
title = "δ-Thalassemia caused by disruption of the site for an erythroid-specific transcription factor, GATA-1, in the δ-globin gene promoter",
abstract = "Delta-thalassemia is a complex group of inherited disorders of globin genes characterized by impaired synthesis of the δ-globin chain. The T-C substitution was detected at position -77 of the δ-globin gene isolated from three independent Japanese individuals who were homozygotes for δ- thalassemia. To elucidate the significance of the mutation in δ-globin gene expression, we investigated the genotype of three δ-thalassemia homozygotes and 58 normal individuals using dot blot hybridization of the polymerase chain reaction (PCR)-amplified DNA. The mutation was observed in six alleles of three homozygotes, while no mutation was detected in 116 alleles of normal individuals, thereby indicating the close association of this mutation with the thalassemia phenotype. Since the mutation (TTATCT-TCATCT) is located within the inverted binding motif of GATA-1 (T or A-G-A-T-A-G or A), an erythroid cell-specific transcription factor, we did gel retardation assays using nuclear extracts from the erythroid cells. We found that GATA-1 binds the oligonucleotide spanning positions -61 to -90, but does not bind to the oligonucleotide with the mutation at position -77. Competition gel retardation assays showed that GATA-1 binding can be competed out by the fragment with the GATA-1 motif, but not with the mutant oligonucleotide. Analysis of the transient expression of the CAT gene linked to the δ-globin gene promoter region demonstrated that the construct with the mutant promoter region was expressed about 20-fold less compared with the normal one. Thus, the mutation at position -77 impairs δ-globin gene expression by abolishing GATA-1 binding to the AGATAA sequence of the promoter region of the δ-globin gene. This provides a good example of involvement of tissue-specific transacting factors in the molecular pathogenesis of hereditary diseases.",
author = "Miho Matsuda and N. Sakamoto and Y. Fukumaki",
year = "1992",
month = "1",
day = "1",
language = "English",
volume = "80",
pages = "1347--1351",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "5",

}

TY - JOUR

T1 - δ-Thalassemia caused by disruption of the site for an erythroid-specific transcription factor, GATA-1, in the δ-globin gene promoter

AU - Matsuda, Miho

AU - Sakamoto, N.

AU - Fukumaki, Y.

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Delta-thalassemia is a complex group of inherited disorders of globin genes characterized by impaired synthesis of the δ-globin chain. The T-C substitution was detected at position -77 of the δ-globin gene isolated from three independent Japanese individuals who were homozygotes for δ- thalassemia. To elucidate the significance of the mutation in δ-globin gene expression, we investigated the genotype of three δ-thalassemia homozygotes and 58 normal individuals using dot blot hybridization of the polymerase chain reaction (PCR)-amplified DNA. The mutation was observed in six alleles of three homozygotes, while no mutation was detected in 116 alleles of normal individuals, thereby indicating the close association of this mutation with the thalassemia phenotype. Since the mutation (TTATCT-TCATCT) is located within the inverted binding motif of GATA-1 (T or A-G-A-T-A-G or A), an erythroid cell-specific transcription factor, we did gel retardation assays using nuclear extracts from the erythroid cells. We found that GATA-1 binds the oligonucleotide spanning positions -61 to -90, but does not bind to the oligonucleotide with the mutation at position -77. Competition gel retardation assays showed that GATA-1 binding can be competed out by the fragment with the GATA-1 motif, but not with the mutant oligonucleotide. Analysis of the transient expression of the CAT gene linked to the δ-globin gene promoter region demonstrated that the construct with the mutant promoter region was expressed about 20-fold less compared with the normal one. Thus, the mutation at position -77 impairs δ-globin gene expression by abolishing GATA-1 binding to the AGATAA sequence of the promoter region of the δ-globin gene. This provides a good example of involvement of tissue-specific transacting factors in the molecular pathogenesis of hereditary diseases.

AB - Delta-thalassemia is a complex group of inherited disorders of globin genes characterized by impaired synthesis of the δ-globin chain. The T-C substitution was detected at position -77 of the δ-globin gene isolated from three independent Japanese individuals who were homozygotes for δ- thalassemia. To elucidate the significance of the mutation in δ-globin gene expression, we investigated the genotype of three δ-thalassemia homozygotes and 58 normal individuals using dot blot hybridization of the polymerase chain reaction (PCR)-amplified DNA. The mutation was observed in six alleles of three homozygotes, while no mutation was detected in 116 alleles of normal individuals, thereby indicating the close association of this mutation with the thalassemia phenotype. Since the mutation (TTATCT-TCATCT) is located within the inverted binding motif of GATA-1 (T or A-G-A-T-A-G or A), an erythroid cell-specific transcription factor, we did gel retardation assays using nuclear extracts from the erythroid cells. We found that GATA-1 binds the oligonucleotide spanning positions -61 to -90, but does not bind to the oligonucleotide with the mutation at position -77. Competition gel retardation assays showed that GATA-1 binding can be competed out by the fragment with the GATA-1 motif, but not with the mutant oligonucleotide. Analysis of the transient expression of the CAT gene linked to the δ-globin gene promoter region demonstrated that the construct with the mutant promoter region was expressed about 20-fold less compared with the normal one. Thus, the mutation at position -77 impairs δ-globin gene expression by abolishing GATA-1 binding to the AGATAA sequence of the promoter region of the δ-globin gene. This provides a good example of involvement of tissue-specific transacting factors in the molecular pathogenesis of hereditary diseases.

UR - http://www.scopus.com/inward/record.url?scp=0026699172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026699172&partnerID=8YFLogxK

M3 - Article

VL - 80

SP - 1347

EP - 1351

JO - Blood

JF - Blood

SN - 0006-4971

IS - 5

ER -